Top Mutual Funds Holders Sold off Big Tech Stocks in Q3-Q4 2022

Wrapmanager Inc has shared its Q3-Q4 2022 13F holdings report, which shows that the top holdings of the biggest mutual funds in the market have sold off big tech stocks. In the report were holdings of 44 stocks in total. But what's more important is the large-scale shift that took place. This was evident in the sale of Amazon by 39.5%, reducing their Q3 2022 shares to 47,101 from 38,337 in Q4 2022. Also, Microsoft saw a rise of 8.1%, making it one of the few gainers in the report. This article will discuss some stocks that were sold off and some that saw a reduction in holdings from the Q3 2022 to Q4 2022 period.

AGG: ISHARES TR

Aggregate Bond Fund saw a reduction of 8.4%, making it one of the worst hit. This investment company owns over $5 trillion in assets and is known for its diversified approach in investments.

ACWV: ISHARES INC

iShares MSCI Global Min Vol Factor ETF, with holdings of giants such as Proctor and Gamble, Coca Cola, and McDonald's, saw a 1.3% decrease in holding. This fund has a focus on companies with lower volatility.

AMZN: AMAZON COM INC

The company experienced the worst hit from Q3 to Q4 2022. The 39.5% drop in holding is one of the biggest drops in the report. The company's valuation dipped by $2,102,000,000. However, the company is still considered one of the best stocks to buy with a long-term outlook. Investors should look to the company's global expansion and the increasing use of its cloud computing services as a source of growth.

AAPL: APPLE INC

Apple's stock is considered a stable long-term investment. The company experienced a 0.5% drop in holdings from the Q3 2022 period to Q4 2022, which puts the stock's value at $31,749,000,000.

GOOG: ALPHABET INC

Alphabet's decline is no different from others in the sector, with shares value declining by $265,000,000. The company remained one of the top holdings in the fund, despite its 8.6% drop in holdings.

ABBV: ABBVIE INC

AbbVie has a well-diversified pipeline of products with sales reaching $60 billion. Its immunology product, Humira, is one of the best selling in the world. The company saw a 24.8% increase in its stock valuation from Q3 to Q4 2022. This is the fourth-highest increase in the report.

GILD: GILEAD SCIENCES INC

Gilead's primary focus is infectious diseases, oncology, and liver disease. The company's stocks witnessed a 45.6% increase in valuation, which is the highest in the report. The company has a diverse pipeline of drugs and a focus on improving patient health.

PFE: PFIZER INC

Apart from their COVID-19 vaccine, the company has a well-diversified portfolio of drugs. The stock saw a 38.7% increase in valuation. This is a good sign for investors looking for a long-term hold.

TMO: THERMO FISHER SCIENTIFIC INC

The company's revenue has been on the rise, mainly due to its diagnostic and biosciences products. The stock saw a 1267% increase in valuation from Q3 to Q4 2022, making it the second-best-performing stock in the report.

HD: HOME DEPOT INC

Home Depot operates as a home improvement retailer with over 2,000 different stores. The company's stock valuation increased by 1419, which is a 15.5% increase in the report.

Conclusion

The Wrapmanager Inc Q3-Q4 2022 13F holdings report showed a decline in most companies, mostly big tech stocks. Despite this, some other stocks witnessed an increase with growth potential for the market. Keep in mind that these decisions by mutual fund holders could be influenced by several factors, including global economic factors and social events. It is always advisable to conduct an in-depth analysis before making investment decisions.